Hyperinflammation Biochip
The Hyperinflammation Biochip can aid intensive and critical care units to monitor the cytokine levels of critically ill patients. As clinicians apply various anti-inflammatory approaches, the patient’s response can be monitored to ensure that the interventions are effective. The biomarker panel is currently useful as a research tool for areas such as Sepsis, Organ Transplant, Diabetes and more.
Biochip Performance
Biomarker | Measuring Range |
Interleukin-1 beta (IL-1β) | 0 - 250 pg/mL |
Interleukin-2 (IL-2) | 0 - 1000 pg/mL |
Interleukin-6 (IL-6) | 0 - 500 pg/mL |
Interferon gamma (IFN-γ) | 0 - 500 pg/mL |
Tumour Necrosis Factor alpha (TNF-α) | 0 - 1000 pg/mL |
Monocyte Chemoattractant Protein-1 (MCP-1) | 0 - 500 pg/mL |
Interleukin-15 (IL-15) | 0 - 1000 pg/mL |
Ferritin | 0 - 1000 ng/mL |
D-Dimer | 0 - 4500 ng/mL |
Benefits of the MultiSTAT
The Evidence MultiSTAT
Meet the Evidence MultiSTAT
The Evidence MultiSTAT is an easy to use, small footprint analyser facilitating on-site simultaneous detection of multiple biomarkers.
Using chemiluminescence as a measurement principle, the Evidence MultiSTAT consistently delivers accurate results.
With minimal sample preparation required, this versatile benchtop analyser can achieve accurate, quantitative results in minutes.
Meet the Cartridge
The Evidence MultiSTAT cartridge contains the reagents required for the chemiluminescent reaction to take place incorporated into its wells.
The process from sample entry to results can be completed in 2 simple steps, with minimal risk of human error.
No other components are required.